Table 1.
Chondrogenic viability after supplementation with hyperacute sera with and without HA.
| HA | ||||||
|---|---|---|---|---|---|---|
| − | + | − | + | − | + | |
| FCS | 1.5722 | 2.1943 | 1.9111 | 1.6714 | 4.1204 | 3.8288 |
| Filtered lyophilized HAS | 1.8737 | 1.8371 | 1.9618 | 1.0740 | 3.2265 | 3.8791 |
| Non-filtered lyo. HAS | 2.9374 | 3.3930 | 3.2409 | 3.3741 | 5.8379 | 7.0123 |
| Day 3 | Day 5 | Day 7 | ||||
Mean chondrocyte viability measured by XTT assay at days 3, 5 and 7, comparing filtered and non-filtered lyophilized HAS in the presence or absence of HA. Data represents fold change (in a.u.) normalized to the “d0” condition (n = 5).